Efficacy of Dupilumab in Pediatric Patients with Uncontrolled, Moderate-to-Severe Asthma With and Without Ongoing Atopic Comorbid Disease: LIBERTY ASTHMA VOYAGE

B15. NOVEL BIOMARKERS AND USES OF THERAPEUTICS IN ASTHMA Pub Date : 2022-05-01 DOI:10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2364

T. Guilbert, A. Deschildre, D. Jackson, P. Bégin, R. Zeiger, S. Szefler, A. Altincatal, R. Gall, J. Jacob-Nara, P. Rowe, Y. Deniz, M. Djandji

引用次数: 0

查看原文本刊更多论文

Dupilumab在伴有或不伴有持续特应性共病的未控制的中重度哮喘患儿中的疗效:LIBERTY Asthma VOYAGE

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

自引率

0.00%

发文量